Recombinant multi-species WNT9A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WNT9A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The WNT gene family consists of structurally related genes that encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family. It is expressed in gastric cancer cell lines. The protein encoded by this gene shows 75% amino acid identity to chicken Wnt14, which has been shown to play a central role in initiating synovial joint formation in the chick limb. This gene is clustered with another family member, WNT3A, in the chromosome 1q42 region. [provided by RefSeq, Jul 2008]
The Alternative Names of target: Protein Wnt-14,Protein Wnt-9a,WNT14,WNT9A,Wnt14,Wnt9a,wnt-14
Go
to WNT9A products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE0559-Ag-1/ GM-Tg-hg-SE0559-Ag-2 | Human WNT9A protein | Human |
| GM-Tg-rg-SE0559-Ag-1/ GM-Tg-rg-SE0559-Ag-2 | Rat WNT9A protein | Rat |
| GM-Tg-mg-SE0559-Ag-1/ GM-Tg-mg-SE0559-Ag-2 | Mouse WNT9A protein | Mouse |
| GM-Tg-cynog-SE0559-Ag-1/ GM-Tg-cynog-SE0559-Ag-2 | Cynomolgus/Rhesus macaque WNT9A protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE0559-Ag-1/ GM-Tg-felg-SE0559-Ag-2 | Feline WNT9A protein | Feline |
| GM-Tg-cang-SE0559-Ag-1/ GM-Tg-cang-SE0559-Ag-2 | Canine WNT9A protein | Canine |
| GM-Tg-bovg-SE0559-Ag-1/ GM-Tg-bovg-SE0559-Ag-2 | Bovine WNT9A protein | Bovine |
| GM-Tg-equg-SE0559-Ag-1/ GM-Tg-equg-SE0559-Ag-2 | Equine WNT9A protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE0559-Ag-1/ GM-Tg-hg-SE0559-Ag-2;
GM-Tg-rg-SE0559-Ag-1/ GM-Tg-rg-SE0559-Ag-2;
GM-Tg-mg-SE0559-Ag-1/ GM-Tg-mg-SE0559-Ag-2; GM-Tg-cynog-SE0559-Ag-1/ GM-Tg-cynog-SE0559-Ag-2; GM-Tg-felg-SE0559-Ag-1/ GM-Tg-felg-SE0559-Ag-2; GM-Tg-cang-SE0559-Ag-1/ GM-Tg-cang-SE0559-Ag-2; GM-Tg-bovg-SE0559-Ag-1/ GM-Tg-bovg-SE0559-Ag-2; GM-Tg-equg-SE0559-Ag-1/ GM-Tg-equg-SE0559-Ag-2 |
| Products Name | WNT9A protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | WNT9A |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WNT9A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.